ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.0137891122538509 -0.0024870629
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0137891122538509 0.62986516
NSC 694075 Null 0.0137891122538509 0.63456443
NSC 702046 Null 0.0137891122538509 0.22662604
NSC 705870 Null 0.0137891122538509 0.055149995
NSC 710002 Null 0.0137891122538509 0.28324448
NSC 713759 Null 0.0137891122538509 0.12343153
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0137891122538509 0.3128879
NSC 730507 Null 0.0137891122538509 0.14213534
NSC 100880 Camptothecin 0.013789112253851 0.0033850312
Total:84  Current:35    [First] [Prev] [Next] [Last]